SEC Form D private-offering filing
PharmassetX Inc.
A new SEC Form D private-offering notice from Louisville, KY, a $20,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Pharmaceutical company developing galenexib, a patent-pending small molecule drug for pouchitis and other inflammatory bowel disease indications.
Filed 2025-10-10Filed to raise $20,000,000First money in 2025-09-10Raised so far $50,000HQ (as filed) Louisville, KYSector Biotech ✓Stage (inferred) EarlyCall status Delayed filing
Source linked the Form D on EDGAR↗Website verified pharmassetx.com↗Named in the filing 3 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.